BOUNDLESS BIO, INC. (BOLD) Operating cash flow 2023–2025
BOUNDLESS BIO, INC. (BOLD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$46.7MFY2025 · since FY2023: -$46.9M → -$46.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$46.7M | +23.3% |
| FY2024 | -$60.8M | -29.8% |
| FY2023 | -$46.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice